Parkinson's Disease Trial, Not Yet Recruiting NCT06980064 Sponsor: Tongji Hospital Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Not Yet Recruiting

NCT06980064
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged 40 to 68 years old (inclusive).
  • People who have at least one of the following risk factors for heart or stroke-related disease: being a male aged 55 or older, or a female aged 65 or older; currently smoking or having quit smoking within the past 3 months; having diabetes (type 1 or 2); having high blood pressure or currently taking blood pressure medication; having abnormal cholesterol or fat levels in the blood; having a high level of a blood marker called hsCRP (above 3.0 mg/L); or having a calculated 10-year risk of heart or blood vessel disease of 20% or more (confirm with trial site for how this is calculated).
  • People who agree to undergo a specialised heart scan called a coronary CT angiography (a detailed X-ray scan of the heart's blood vessels) if the trial team suspects a blockage.
  • People who have voluntarily agreed to participate and have signed a consent form.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have already been diagnosed with coronary artery disease, or who have previously had a heart scan or procedure showing a moderate to severe blockage (50% or more narrowing) in the heart's arteries.
  • Women who are pregnant or planning to become pregnant within the next year.
  • People who are currently unwell and require treatment in hospital.
  • People who have tattoos or other substances on their wrist that may interfere with an optical sensor reading.
  • People with certain serious heart rhythm problems, including specific conditions such as atrial fibrillation, ventricular tachycardia, or other significant rhythm disorders (confirm with trial site for the full list).
  • People with a physical disability, blindness, or deafness.
  • People who have had an allergic reaction to iodine-based contrast dye in the past.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Cuntai Zhang, PhD, Wuhan TongJi Hospital

Phone: 86 13627115411

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Tongji Hospital
Registry
ClinicalTrials.gov
Start date
1 June 2025
Est. completion
31 December 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Primary endpoints

Coronary heart disease

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov